Clinical Trial Update: Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety of RSD1235 in patients with atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• RSD1235

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED